Log in
Enquire now
‌

US Patent 7976871 Modified release composition of highly soluble drugs

Patent 7976871 was granted and assigned to Torrent Pharmaceuticals on July, 2011 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
Torrent Pharmaceuticals
Torrent Pharmaceuticals
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7976871
Patent Inventor Names
Rajesh Singh Karan0
Vinod Kumar Gupta0
Navin Vaya0
Sunil Sadanand Nadkarni0
Date of Patent
July 12, 2011
Patent Application Number
11134631
Date Filed
May 19, 2005
Patent Citations Received
‌
US Patent 11654113 Modified release formulations and uses thereof
0
‌
US Patent 11767293 Crystal forms and production methods thereof
Patent Primary Examiner
‌
Anand U Desai
Patent abstract

A novel modified release dosage form comprising of a high solubility active ingredient, which utilizes dual retard technique to effectively reduce the quantity of release controlling agents. Present invention can optionally comprise additionally another active ingredient as an immediate release form or modified release form. Present invention also relates to a process for preparing the said formulation.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7976871 Modified release composition of highly soluble drugs

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.